Literature DB >> 10948785

Effect of a pharmacist-managed diabetes care program in a free medical clinic.

M B Davidson1, V J Karlan, T L Hair.   

Abstract

Diabetes care, morbidity, and mortality are usually worse in poor minority populations compared with non-minority ones. This report evaluates evidence-based process and outcome measures of diabetes care in diabetic patients followed in a free medical clinic and compares them to published results. The following process measures compared favorably with measures of the general population: dilated eye and foot exams and measurements of glycated hemoglobin levels; concentrations of total cholesterol; fasting triglycerides and low density lipoprotein (LDL) cholesterol; and proteinuria (by dipstick). Process and outcome measures in 89 diabetic patients referred to a Diabetes Management Program in which diabetes care was delivered by pharmacists following detailed algorithms (experimental group) were compared with measures in 92 diabetic patients who received diabetes care in the general clinic setting (control group). The patients in the experimental group had a slightly longer duration of diabetes and more microvascular and neuropathic complications, and more diabetic patients were taking insulin than were patients in the control group. All of the process measures listed above were more frequent in the experimental group. Compared with the control group, the initial glycated hemoglobin level (% +/- SE) in the experimental group was significantly (P < .001) higher (8.8 +/- 0.2 versus 7.9 +/- 0.2) but fell significantly (P < .03) more (-0.8 +/- 0.2 versus -0.05 +/- 0.3). The lack of a greater decrease in the glycated hemoglobin levels in the experimental group was not related to the inability of the pharmacists to follow the algorithms, the patients' refusal to follow the recommended medication adjustments, or the lack of appropriate self-monitoring of blood glucose in insulin-requiring patients. It was inversely related (r = -0.36, P < .03) to the number of missed visits, i.e., the greater the number of broken appointments, the less the glycated hemoglobin fell. In conclusion, diabetes care for a poor minority population in a free clinic setting can compare favorably to care in the general population. Pharmacists following detailed algorithms can enhance this care further. Administrative and support system changes that minimize the number of missed visits might further improve diabetes care in this population.

Entities:  

Mesh:

Year:  2000        PMID: 10948785     DOI: 10.1177/106286060001500403

Source DB:  PubMed          Journal:  Am J Med Qual        ISSN: 1062-8606            Impact factor:   1.852


  22 in total

1.  A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain.

Authors:  José A Fornos; N Floro Andrés; J Carlos Andrés; M Mercedes Guerra; Beatriz Egea
Journal:  Pharm World Sci       Date:  2006-06-22

2.  Assessing the effectiveness of pharmacist-directed medication therapy management in improving diabetes outcomes in patients with poorly controlled diabetes.

Authors:  Jeannine S Skinner; Brett Poe; Rebecca Hopper; Alaina Boyer; Consuelo H Wilkins
Journal:  Diabetes Educ       Date:  2015-05-25       Impact factor: 2.140

3.  Pharmacists' perceived barriers providing non-dispensing services to underserved populations.

Authors:  Lucas Blazejewski; Varun Vaidya; Sharrel Pinto; Caroline Gaither
Journal:  J Community Health       Date:  2013-10

4.  Cancelled Primary Care Appointments: A Prospective Cohort Study of Diabetic Patients.

Authors:  Sara McComb; Zhiyi Tian; Laura Sands; Ayten Turkcan; Lingsong Zhang; Shree Frazier; Mark Lawley
Journal:  J Med Syst       Date:  2017-02-18       Impact factor: 4.460

Review 5.  A Systematic Review of Community Health Center Based Interventions for People with Diabetes.

Authors:  Hae-Ra Han; Siobhan McKenna; Manka Nkimbeng; Patty Wilson; Sally Rives; Olayinka Ajomagberin; Mohammad Alkawaldeh; Kelli Grunstra; Nisa Maruthur; Phyllis Sharps
Journal:  J Community Health       Date:  2019-07-06

6.  The pharmaceutical care of patients with type 2 diabetes mellitus.

Authors:  Anna Paula de Sá Borges; Camilo Molino Guidoni; Lígia Domingues Ferreira; Osvaldo de Freitas; Leonardo Régis Leira Pereira
Journal:  Pharm World Sci       Date:  2010-08-24

Review 7.  Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns.

Authors:  Nancy Nkansah; Olga Mostovetsky; Christine Yu; Tami Chheng; Johnny Beney; Christine M Bond; Lisa Bero
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

8.  Evaluating Adherence to Dilated Eye Examination Recommendations Among Patients with Diabetes, Combined with Patient and Provider Perspectives.

Authors:  Maxine D Fisher; Yamina Rajput; Tao Gu; Joseph R Singer; Amanda R Marshall; Seonyoung Ryu; John Barron; Catherine MacLean
Journal:  Am Health Drug Benefits       Date:  2016-10

Review 9.  Patient education for preventing diabetic foot ulceration.

Authors:  Johannes A N Dorresteijn; Didi M W Kriegsman; Willem J J Assendelft; Gerlof D Valk
Journal:  Cochrane Database Syst Rev       Date:  2014-12-16

Review 10.  A review of advances in collaborative pharmacy practice to improve adherence to standards of care in diabetes management.

Authors:  Michael P Conley; Christine Chim; Chelsea E Magee; Daniel J Sullivan
Journal:  Curr Diab Rep       Date:  2014-03       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.